FDA Investigator Yanming An, PhD
Yanming An, PhD has conducted inspections on 6 sites in 4 countries as of 10 Jun 2019. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
6
Last Inspection Date:
10 Jun 2019
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Germany,
United States of America,
Singapore,
Switzerland
FDA Investigators that have inspected at least one site in common with Yanming An, PhD:
Aimee Cunningham, PhD,
Alan L Truong,
Amy Devlin, PhD,
Anastasia G Lolas,
Andrew J Barrowcliff,
Anh M Lac,
Anissa M Cheung,
Anita Narula, PhD,
Ann L Demarco,
Ann Marie Montemurro,
Arie C Menachem,
Arindam Dasgupta, PhD,
Azza Talaat,
Bo Chi, PhD,
Brandon C Heitmeier,
Brenda P King,
Brenda W Uratani, PhD,
Brentley S Collins,
Burnell M Henry,
Carl A Anderson,
Charles I Ann,
Charles M Edwards,
Charles Yuanchia Kuo, PhD,
Christian D Lynch (CDL),
Christina Capacci Daniel, PhD,
Christopher Downey, PhD,
Concepcion Cruz, Jr,
Cristina Ausin Moreno, PhD,
David Doleski,
Dawn M Braswell,
Diane L Raccasi,
Doan T Nguyen, PharmD,
Donald C Obenhuber, PhD,
Dr. Ralph M Bernstein, PhD,
Dr. Zhihao Qiu (Peter), PhD,
Eboni S Funderburk,
Edwin Jao,
Ekaterina Allen,
Eliezar Ramos,
Ellen P Madigan,
Emilie E Kahn,
Erika V Butler,
Esther C Broner, PhD,
Felix Maldonado,
Gene D Arcy,
Gunther Boekhoudt, PhD,
Gwyn G Dickinson,
Helen B Ricalde,
Hyung Yul Lee,
J David Doleski,
Jacob G Lutz,
James A Lane,
Jee Chung, PhD,
Jeffrey D Meng,
John D White,
Jon P Antoniou,
Jose Acruz Gonzalez,
Joslyn K Brunelle, PhD,
Joyce A Rockwell,
Julie D Bringger,
Junho Pak,
Justine M Corson,
Kalavati Suvarna, PhD,
Kara A Scheibner, PhD,
Katherine E Jacobitz,
Kathleen R Jones, PhD,
Kent C Faul,
Kevin A Gonzalez,
Kevin D Kallander,
Kim Lthomas Cruse,
Kurt A Brorson, PhD,
LCDR Debra Emerson,
LCDR Sean Byrd,
Lixin Xu, MD, PhD,
Logan T Williams,
Madushini Dharmasena, PhD,
Maria Cruz Fisher,
Marie F Morin,
Mariza M Jafary,
Mark Brunswick, PhD,
Martha T Olone,
Mary E Storch,
Maxwell Van Tassell, PhD,
Megan A Haggerty,
Meisha R Sampson,
Meisha Waters,
Michael Shanks, MS,
Michele L Forster, PhD,
Michele Perry Williams,
Michelle M Noe Varga,
Michelle Yclark Stuart,
Mihaly S Ligmond,
Milos Dokmanovic, PhD,
Minh D Phan,
Mohsen Rajabi Abhari, FDA,
Monica Commerford, PhD,
Monique C Lo,
Mra Munizn,
Muna Algharibeh,
Nailing Zhang,
Nicholas L Paulin,
Ogechi C Nna,
Omotunde O Osunsanmi,
Patricia F Hughes, PhD,
Paula A Trost,
Peter R Lenahan,
Prabhu P Raju,
Priscilla M Pastrana,
Qing Joanna Zhou, PhD,
Rabia Ballica, PhD,
Rafeeq A Habeeb,
Ramesh Potla, PhD,
Rebecca Rodriguez,
Reyes Candau Chacon, PhD,
Richard H Penta,
Richard Ledwidge (nmi), PhD,
Richard W Berning,
Richard W Thornton,
Robert Barbosa,
Robert C Coleman,
Robert J Martin,
Robert Jennings,
Robert M Barbosa,
Rose Ashley,
Sandra A Boyd,
Santos E Camara,
Sarah Johnson, PhD,
Sargum C Sood,
Scott R Nichols, PhD,
Sean R Marcsisin,
Seth A Mailhot,
Sharon K Thoma, PharmD,
Sidney B Priesmeyer,
Sneha S Patel,
Stacey S Degarmo,
Stephen D Brown,
Thomas E Friel,
Thuy T Nguyen, LCDR,
Timothy J Schmidt,
Vaishali J Patel,
Veronica Fuentes, MS,
Victor J Gangi,
Virgilio F Pacio, CSO,
Viviana Matta,
Walter N Lange,
Wayne E Seifert,
Wendy G Tan, PhD,
Yasamin Ameri,
Yuan Chia Kuo,
Zerita White,
Zhong Li, PhD,
Ziyang Su, PhD
Yanming An, PhD's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2018 | EIR | Catalent Indiana, LLC - EIR, 2018-05-01 |
May, 2018 | FDA 483 | Catalent Indiana, LLC - Form 483, 2018-05-01 |
June, 2019 | EIR | LONZA BIOLOGICS TUAS PTE. LTD. - EIR, 2019-07-09 |
June, 2019 | FDA 483 | LONZA BIOLOGICS TUAS PTE. LTD. - Form 483, 2019-06-18 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more